0001144204-17-044232.txt : 20170818 0001144204-17-044232.hdr.sgml : 20170818 20170818180028 ACCESSION NUMBER: 0001144204-17-044232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170816 FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Priebe Waldemar CENTRAL INDEX KEY: 0001678516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 171041845 MAIL ADDRESS: STREET 1: 2575 W. BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 4 1 v473534_4.xml FORM 4 X0306 4 2017-08-16 0 0001659617 Moleculin Biotech, Inc. MBRX 0001678516 Priebe Waldemar C/O MOLECULIN BIOTECH, INC. 2575 WEST BELLFORT, SUITE 333 HOUSTON TX 77054 0 0 1 0 Common Stock 2017-08-16 4 S 0 100000 1.703 D 2781573 D The reporting person entered into a private sale agreement for the shares of common stock set forth in the table. In addition to the shares held directly by the reporting person, The reporting person is a shareholder and control person of IntertechBio Corp. IntertechBio Corp. holds 630,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp. The reporting person is also a shareholder and control person of Houston Pharmaceuticals, Inc. Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc. /s/ Waldemar Priebe 2017-08-18